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Primary cardiac tumors are extremely rare and constitute only about 5% of all cardiac tumors. Cardiac myxomas are
noncancerous primary tumors of the heart and constitute about of 50% of all primary heart tumors. Left-sided atrial myxomas
are more common than right-sided atrial myxomas. Atrial myxomas can lead to a triad of complications. The most common
symptoms are associated with obstruction due to the size and location of the tumor. The next most common symptoms are
associated with pulmonary and systemic embolization. Patients may also present with constitutional symptoms. Diagnosis is
made via means of transesophageal echocardiography and magnetic resonance imaging. Early diagnosis and surgical
resection remain the treatment of choice to prevent complications. Patients usually have a good prognosis after resection.
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Primary cardiac tumors are extremely rare andconstitute only about 5% of all cardiac tumors
[1–3]. Cardiac myxomas are noncancerous pri-
mary tumors of the heart and constitute about of
50% of all primary heart tumors [4]. Approxi-
mately 75% of them arise from the left atrium,
20% of them from the right atrium, and 5% in both
atria and the ventricle [2]. Cardiac myxomas pre-
dominantly occur in women [5] with an average
age of onset in the 6th decade of life [6]. Rare
occurrences of atrial myxoma in a pediatric age
group have also been reported [7]. Li et al. [8] eval-
uated the occurrence of cardiac myxomas in men
and women. He found that the ratio of women to
men for left atrial myxomas was 2.05:1, while that
of right atrial myxomas was 0.75:1 [8]. A French
study conducted by Pinede et al. [9] showed that
myxomas can lead to a triad of complications,
the first being obstruction (67%), followed by
emboli (29%), with or without constitutional
symptoms (34%).
Often myxomas mimic multiple cardiovascular
diseases and hence demand a high degree of
suspicion for diagnosis [10]. Apart from cardiac
manifestations, there are many extracardiac
manifestations associated with atrial myxomas
which can be often misdiagnosed or confused
with other medical conditions. Currently, there
has been no published review regarding the
extracardiac manifestations of atrial myxomas.
The primary objective of our review is to outline
and discuss all the extracardiac manifestations of
atrial myxomas and their associated complications
and prognosis.Figure 1. Illustration of the common sites of right and left atrial
myxomas.Methodology
A systematic review of the MEDLINE database
was conducted using the PubMed search engine.
We included all articles published in the English
language between January 1, 1950, and April 30,
2016. In PubMed, the combination of medical text
terms used included ‘‘atrial myxomas,’’ ‘‘extracar-
diac manifestations,’’ and ‘‘extracardiac symp-
toms.’’ Primarily we selected publications within
the last 25 years but did not exclude older publica-
tions that were highly regarded. We also searched
the reference lists of the manuscripts by this strat-
egy and selected those to be relevant. All perti-
nent reports and the relative reference lists were
searched to identify any additional studies thatcould be included. All data were accessed
between February 2016 and April 2016.Myxomas
Left atrial myxomas
The most common location of myxomas is the
left atrium, classically at the fossa ovalis border
of the interatrial septum [6] or at the mitral annu-
lus [8] (Fig. 1). They commonly present with sys-
temic or constitutional symptoms. Cases have
been reported where a myxoma was diagnosed
as a large, asymptomatic incidental mass on
echocardiogram. In a study conducted by Gos-
wami et al. [11], 80% of patients with a cardiac
myxoma presented with dyspnea. Other present-
ing symptoms included palpitations, syncope,
pedal edema, chest pain, and constitutional symp-
toms. Around 30% of the patients presented with
signs and symptoms associated with secondary
embolization [11,12]. These patients are often mis-
diagnosed as having mitral valve disease, tricus-
pid valve disease, ischemic heart disease, or
cardiomyopathy.
Right atrial myxomas
The second most common location for cardiac
myxomas is the right atrium with the most com-
mon site of attachment being the interatrial sep-
tum, followed by the vena cava, at or near the
coronary sinus [8] (Fig. 1). Right atrial myxomas
are mostly asymptomatic [13]. Similar to left atrial
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EXTRACARDIAC MANIFESTATIONS OF ATRIAL MYXOMASmyxomas, right atrial myxomas can also present
with obstructive symptoms producing intracar-
diac flow disturbances, embolic symptoms—both
pulmonary and systemic—(paradoxical emboli
through patent foramen ovale) [14], and constitu-
tional symptoms.Histopathology
Different theories explain the origin ofmyxomas.
Recent literature explains the origin of stromal cells
by two hypotheses. One states that it is derived
fromendocardial neural cells [15], while other liter-
ature states that myxomas originate from the
embryonic foregut and are thus derived frommul-
tipotent mesenchymal cells capable of neural and
epithelial differentiation. Although the etiology is
not well understood, the majority of cases are spo-
radic and approximately 10%ofmyxomas are of the
autosomal dominant genetic pattern (Carney’s
complex) [16]. On gross anatomy, cardiacmyxomas
are oftenpedunculated and soft in consistencywith
a smooth, villous, or friable surface. They usually
weigh anywhere between 15 g and 180 g and their
average size is between 2 cm and 6 cm [17]. The
smooth myxomas are often large and are responsi-
ble for obstructive symptoms, while the villous and
friable myxomas are usually responsible for the
embolic phenomenon [9,18]. Histologically, they
aremade of stellated, fusiform, andpolygonal cells,
within a mucopolysaccharide stroma. Immunohis-
tochemically some are positive for CD31, CD34,
and FVIIIAg. They can also stain positive for
vimentin, desmin, smooth muscle myosin, CD56,
S-100 protein, calretinin, a1 antitrypsin, and a1
antichymotrypsin [19]. Occasionally fibrocytes,
smooth muscle cells, lymphocytes, and plasma-
cytes are also seen in the matrix [20]. Calcifications
are present in approximately 10% of the myxomas
[21]. Cardiac myxomas often synthesize vascular
endothelial growth factor, which is responsible for
significant angiogenesis [22–24]. The most impor-
tant differential diagnosis for cardiac myxoma is
mural thrombi with myxoid stroma. The similar
histopathological appearance makes the diagnosis
extremely challenging. Immunohistochemistry
testing is of low value. In such cases, the calretinin
marker, which is specific formyxomas, helps to dif-
ferentiate it from mural myxoid thrombi [25].
Often, other cardiac tumors including malignant
tumors can mimic myxomas and there have been
few reports of a malignant transformation of an
existing cardiacmyxoma [26]. One report describes
a patient developing primary cardiac sarcoma
within a pre-existing atrial myxoma [27]. Anotherinterestinghistopathological report in cardiacmyx-
oma is the presence of primary cardiac lymphoma
within a cardiac myxoma. Epstein–Barr virus was
associated with the development of CD30-positive
large B-cell lymphomawith anaplasticmorphology
within the cardiac myxoma [28].Cardiac and extracardiac manifestations
Obstructive symptoms
Obstructive symptoms usually depend on the
site of the cardiac myxoma. Patients with left atrial
myxomas may develop mitral valve regurgitation
or stenosis depending upon the site of attachment
[29]. When the tumor is located close to the mitral
valve orifice, it results in obstruction and presents
with symptoms of left heart failure symptoms and
pulmonary congestion. Local invasion of the
tumor can lead to conduction abnormalities and
arrhythmias [30]. The most common presentation
of atrial myxomas is dyspnea with exertion fol-
lowed by orthopnea, paroxysmal nocturnal dysp-
nea, and pulmonary edema [11]. Careful physical
examination including a good cardiac auscultation
plays a vital role in the initial diagnosis. A retro-
spective study conducted by Aggarwal et al. [31]
reported that approximately 89% of the patients
had an auscultation abnormality and around
50% of them had a tumor plop. Echocardiogram
usually demonstrates left atrial enlargement and
cardiomegaly may be seen on ta chest x-ray [31].
Similar to the left side, the obstructive symp-
toms of right atrial myxomas depend on the site
of attachment. The myxoma can be at the level
of tricuspid valve causing obstructive symptoms,
which mimics tricuspid stenosis. Rarely these
patients can present with tricuspid regurgitation.
A murmur may be appreciated over the tricuspid
region with tricuspid regurgitation seen on the
echocardiogram. Over time, symptoms of right-
sided heart failure will develop such as pedal
edema, hepatic congestion, exertional dyspnea,
and ascites. Massive obstruction can lead to syn-
cope and decompensated right-sided heart failure
[32]. Similar to the left side, right-sided myxomas
can also invade the myocardium causing conduc-
tion abnormalities and associated arrhythmias.
Embolic symptoms
Embolization commonly occurs in about 35% of
all left atrial myxomas [6]. Villous and friable myx-
omas are the myxomas that are predominantly
responsible [33]. It is actually the overlying throm-
bus on the surface of the tumor that embolizes
more than the tumor itself [34]. A smaller tumor
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to the high systolic left ventricular pressure,
embolization due to left atrial myxomas com-
monly affects the central nervous system and reti-
nal arteries. Embolization can also occur in the
lower extremities (commonly iliac and femoropo-
pliteal), viscera, spleen, adrenals, kidneys, and
even the abdominal aorta [35]. The patient can
present with dyspnea, transient ischemic attack,
hemiplegia, syncope, loss of vision, arrhythmia,
and chest pain. Symptoms may include Raynaud’s
phenomenon, spotty skin pigmentation, abdomi-
nal pain, diarrhea, and other peripheral signs of
embolization [15]. Approximately 10% of coronary
embolizations are believed to be due to cardiac
myxomas. In specific to patients with myxomas,
studies report that around 20–35% of them experi-
ence neurological complications [9] and 9–22% of
these myxoma cases suffer from an embolic stroke
[16]. Left atrial myxoma should always be
included in the differential diagnosis in case of
multiple cerebral infarcts, especially in young
individuals [16]. A delayed neurological complica-
tion of a myxoma includes the development of
cerebral aneurysms and myxomatous metastasis.
They tend to present with symptoms similar to
central nervous system vasculitis and infective
endocarditis [35]. Sakellaridis et al. [36] reported
an uncommon case of left atrial myxoma present-
ing with Gerstmann’s syndrome. Embolic occlu-
sion of the retinal arteries may lead to
irreversible vision loss [37]. Cases of ophthalmic
artery occlusion have also been reported [38].
Other ophthalmological manifestations secondary
to cardiac myxomas includes nystagmus, homony-
mous hemianopia, and ocular motility disorders
[37]. A rare catastrophic complication of cardiac
myxoma is an abdominal aortic occlusion. Most
of these cases tend to be infrarenal in nature [39].
Embolization occurs in about 10% of right atrial
myxomas [6]. Embolization in right atrial myxo-
mas can be of two types: (1) pulmonary artery
embolism or systemic embolization if the patient
has a patent foramen ovale or an atrial septal
defect [14]; (2) pulmonary artery embolization is
often life threatening and may require an immedi-
ate pulmonary embolectomy to prevent the devel-
opment of pulmonary artery hypertension and
consequent right ventricular dysfunction [40].
One of the delayed complications includes the
development of a pulmonary artery aneurysm.
The development of an aneurysm secondary to a
myxoma is explained by two theories. One states
that the embolic tumor cells cause inflammation
and degrades the vascular wall leading to aneur-ysm formation [41]. The other states that the meta-
static tumor cells penetrate the vessel wall and
undergo subintimal proliferation leading to weak-
ening of vascular integrity and thus aneurysm
development [42]. A computer tomography pul-
monary angiography provides valuable informa-
tion regarding the pulmonary vasculature, lung
parenchyma, and the cardiac mass in cases where
aneurysms are suspected [30].
Constitutional symptoms
Constitutional symptoms are found to be
reported more in women compared with men
[9]. Constitutional symptoms are more common
in cases of right-sided as opposed to left-sided
cardiac myxomas for unknown reasons. It
includes malaise, anorexia, fever, arthralgia,
weight loss, and often mimics connective tissue
disorders [6]. The symptoms are attributed to the
release of cytokine interleukin-6 (IL-6). Laboratory
abnormalities such as high erythrocyte sedimen-
tation rate, anemia, leukocytosis, thrombocytope-
nia, and elevated gamma globulins can also be
present [43]. Cultured myxoma cells from patients
experiencing constitutional symptoms have
shown elevated levels of messenger RNAs specific
for IL-6 [18]. IL-6 facilitates the proliferation and
differentiation of cells as well as the release of
acute phase reactants during inflammation [18].
It also plays a significant role in the recurrence
of atrial myxomas [18]. Prompt cardiac evaluation
is extremely significant in patients presenting with
nonspecific symptoms as early recognition of
tumor aids in preventing complications and in
improving quality of life (Table 1).
Other symptoms
Apart from the above-mentioned symptoms,
other rare symptoms have been reported in
patients with atrial myxoma. Atrial myxoma can
present with symptoms of acute psychosis. Com-
puter tomography scan and magnetic resonance
imaging of the brain revealed multiple chronic
infarcts which were hypothesized to have occurred
from embolization of atrial myxomas, as the
patient eventually got better after the removal of
the myxoma [44]. Atrial myxomas can be part of a
syndrome such as Carney complex. Carney com-
plex is a rare autosomal dominant syndrome char-
acterized by pigmented lesions of the skin along
with endocrine, cutaneous, cardiac, and neural
myxomatous tumors. Often these are young
patients with widely distributed cutaneous lesions
with a tendency to recur following excision [45].
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EXTRACARDIAC MANIFESTATIONS OF ATRIAL MYXOMASAnother author has also reported the association
of acromegaly in a patient with Carney’s complex
and left atrial myxoma. The patient described in
this report had recurrent atrial myxomas requiring
multiple surgeries who eventually presented with
symptoms of acromegaly and magnetic resonance
imaging of the brain confirmed the diagnosis [46].
Michaud et al. [47] reported the involvement of
the peripheral nervous system with multiple
mononeuropathies in patients with atrial myxoma.
The patient described had symptoms of neurolog-
ical pain, purpuric macules on the palms and soles,
and multiple infarcts in the kidneys and spleen.
These symptoms resolved after removal of
the atrial myxoma. The pathophysiological mecha-
nism includes multiple systemic infarctions from
tumor fragmentations versus paraneoplastic and
an autoimmune process [47]. Coronary steal syn-
drome has been reported in a patient with atrial
myxoma. The patient described in this report had
recurrent exertional chest discomfort and angiog-
raphy revealed a large intracardiac left atrial mass
supplied by two anomalous coronary arteries.
After removal of the mass, which was identified
as myxoma, the patient’s symptoms resolved [48].
Cardiac myxomas can also be a nidus for infection.
Yuan [49] has described around 39 reports involv-
ing 39 patients with infected cardiac myxomas. The
risk factors for infection of myxoma include dental
procedures, infections, invasive procedures, and
immunocompromised state. Common pathogens
include streptococcus viridans, staphylococci, and
Enterococcus faecalis. Patients had complications
such as sepsis, disseminated intravascular coagu-
lation, and embolic events. Prolonged antibiotics
along with surgical resection were necessary for
the treatment and death was reported in two
patients [49].Management
The diagnostic modality of choice is an echocar-
diography, which identifies the size, site, attach-
ment, mobility, and also grossly differentiates
the myxoma from vegetation or a thrombus [50].
Transesophageal echocardiography is preferred
over transthoracic echocardiography [16]. Other
diagnostic tests include a coronary angiography
and magnetic resonance imaging. The treatment
of choice is surgical excision which is aimed at
complete resection and has excellent outcomes.
Surgical excision is also followed by a pericardial
patch placement for the construction of defects
not amenable to primary closure. Histopathologi-
cal analysis of the tumor is suggested to rule out
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and growth rate of the tumor [51].
Apart from surgical excision of the myxoma,
management of symptoms caused by the myxoma
is also necessary. Left sided atrial myxoma can
obstruct the functioning of the mitral valve lead-
ing to symptoms of congestive heart failure.
Diuretics are necessary for treating the pulmonary
vascular congestion secondary to diastolic heart
failure. Since the left ventricular systolic function
is within normal limits, drugs such as beta block-
ers, spironolactone, and angiotensin-converting
enzyme inhibitors are usually not indicated in
these patients [11,30]. Local invasion of the tumor
can cause cardiac arrhythmias requiring antiar-
rhythmic drugs and anticoagulation if indicated.
Right-sided atrial myxomas can lead to symptoms
of right-sided heart failure requiring diuretics for
symptomatic relief [52]. Long-term continuation
of these medications is not necessary as surgical
excision of the tumor provides relief of these
symptoms. Myxomas can also encroach upon the
valves causing damage to them requiring surgical
repair. Embolization of atrial myxomas or throm-
bus overlying the atrial myxoma can cause a myr-
iad of symptoms depending on the location of the
embolus. Currently, there is no clear literature or
guideline commenting on anticoagulation in these
patients. Often patients present to the hospital
with symptoms secondary to embolization. Anti-
platelet and anticoagulant agents are used for sec-
ondary prevention after an event of an ischemic
stroke [53]. Surgical excision of the friable mass
is considered therapeutic for all these patients
[54]. Surgery in patients with a recent embolic
stroke can be complicated due to the potential
for hemorrhagic conversion upon the use of anti-
coagulation during surgery [34]. Constitutional
symptoms are very nonspecific not requiring any
specific treatment and they resolve after excision
of the myxoma [52]. Other rare symptoms as men-
tioned above require specific symptom-oriented
treatment. Despite the fact that the majority of
myxomas are benign in nature, surgical resection
is highly suggested to prevent devastating compli-
cations including sudden death [12,29].Prognosis
Recent literature states that cases of cardiac
myxomas have low surgical mortality and show
good long-term survival results. Recurrence rates
are reported to be extremely low except for famil-
ial myxomas and multicentric cardiac myxomas
[35]. The recurrence rates are noted to be 1–3%
in sporadic forms, 12% in familial forms, and22% in complex myxomas [9]. Interestingly, Wang
et al. [35] found that more often than not, the site
of recurrence is noted to be different from the
original lesion. Minimal tumor manipulation, ade-
quate exposure for complete tumor excision, and
thorough inspection of the four chambers during
surgery were put forth by Jones et al. [55] as steps
essential to prevent recurrence. Regular follow-up
with echocardiography is highly recommended
after surgical excision [6].Conclusion
Atrial myxomas are the most common type of
primary cardiac tumors. Left atrial myxomas are
more common than right atrial myxomas. They
often cause a myriad of clinical signs and symp-
toms that can be classified as obstructive, embolic,
or constitutional. Even though atrial myxomas are
benign tumors, secondary complications due to
their position and possibility of embolization can
be devastating. A high clinical suspicion, prompt
diagnosis with appropriate imaging modalities,
and early surgical resection are important in pre-
venting these complications.References
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